Beam Therapeutics Inc. Other Accrued Liabilities, Current
Beam Therapeutics Inc. (BEAM) had Other Accrued Liabilities, Current of $9.06 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Payables and Accruals › Accrued Liabilities, Current
us-gaap:OtherAccruedLiabilitiesCurrent · last filed 2026-08-04
- 2026-06-30: Other Accrued Liabilities, Current $9.06M.
- 2026-03-31: Other Accrued Liabilities, Current $9.15M.
- 2025-12-31: Other Accrued Liabilities, Current $1.99M.
- 2025-09-30: Other Accrued Liabilities, Current $2.71M.
| Period end | Other Accrued Liabilities, Current | Other Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $9.06M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $9.15M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $1.99M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $2.71M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $2.24M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $3.43M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $7.81M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $2.58M 10-Q · filed 2024-11-05 | |
| 2024-06-30 | $23.54M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $27.05M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $28.64M 10-K · filed 2025-02-25 | $28.16M 10-K · filed 2024-02-27 |
| 2023-09-30 | $4.78M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $7.52M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $11.10M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $12.26M 10-K · filed 2024-02-27 | |
| 2022-09-30 | $13.09M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $10.03M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $4.91M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $6.96M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $5.12M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $4.13M 10-Q · filed 2021-08-10 | |
| 2020-12-31 | $4.23M 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |